Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

BACKGROUND. The antifungal drug itraconazole inhibits angiogenesis and Hedgehog signaling and delays tumor growth in murine prostate cancer xenograft models. We conducted a noncomparative, randomized, phase II study evaluating the antitumor efficacy of two doses of oral itraconazole in men with meta...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Antonarakis, Emmanuel S., Heath, Elisabeth I., Smith, David C., Rathkopf, Dana, Blackford, Amanda L., Danila, Daniel C., King, Serina, Frost, Anja, Ajiboye, A. Seun, Zhao, Ming, Mendonca, Janet, Kachhap, Sushant K., Rudek, Michelle A., Carducci, Michael A.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2013
Teme:
Genitourinary Cancer: Prostate
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579600/
https://ncbi.nlm.nih.gov/pubmed/23340005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-314
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki